Search

Jerry B. Dennison

Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )

Most Active Art Unit
2443
Art Unit(s)
2443, 2409, 2143, 2419
Total Applications
1015
Issued Applications
700
Pending Applications
74
Abandoned Applications
250

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17426896 [patent_doc_number] => 20220054604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => Stabilised Compositions of Factor VII Polypeptides [patent_app_type] => utility [patent_app_number] => 17/231769 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231769 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231769
Stabilised Compositions of Factor VII Polypeptides Apr 14, 2021 Abandoned
Array ( [id] => 18451484 [patent_doc_number] => 20230192762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => Keratin Filament Networks [patent_app_type] => utility [patent_app_number] => 17/917425 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917425 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917425
Keratin Filament Networks Apr 12, 2021 Pending
Array ( [id] => 17460590 [patent_doc_number] => 20220073895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => HUMAN COAGULATION FACTOR VII POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 17/228130 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228130 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228130
HUMAN COAGULATION FACTOR VII POLYPEPTIDES Apr 11, 2021 Abandoned
Array ( [id] => 18436428 [patent_doc_number] => 20230183722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => GENE EXPRESSION SYSTEM FOR RAPID CONSTRUCTION OF MULTIPLE-GENE PATHWAY IN OLEAGINOUS YEASTS [patent_app_type] => utility [patent_app_number] => 17/995624 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995624 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995624
GENE EXPRESSION SYSTEM FOR RAPID CONSTRUCTION OF MULTIPLE-GENE PATHWAY IN OLEAGINOUS YEASTS Apr 6, 2021 Pending
Array ( [id] => 17399946 [patent_doc_number] => 20220042036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => METHODS AND COMPOSITIONS FOR PREPARING SURFACTANT PROTEIN D (SP-D) [patent_app_type] => utility [patent_app_number] => 17/212895 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212895 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/212895
METHODS AND COMPOSITIONS FOR PREPARING SURFACTANT PROTEIN D (SP-D) Mar 24, 2021 Abandoned
Array ( [id] => 19158035 [patent_doc_number] => 20240150742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => GENE FOR EFFICIENTLY EXPRESSING HYALURONIC ACID HYDROLASE AND EXPRESSION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 18/280403 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280403 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/280403
GENE FOR EFFICIENTLY EXPRESSING HYALURONIC ACID HYDROLASE AND EXPRESSION METHOD THEREOF Mar 22, 2021 Pending
Array ( [id] => 17050538 [patent_doc_number] => 20210259972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS [patent_app_type] => utility [patent_app_number] => 17/208736 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16663 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/208736
THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS Mar 21, 2021 Abandoned
Array ( [id] => 18293644 [patent_doc_number] => 20230103330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-06 [patent_title] => MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS [patent_app_type] => utility [patent_app_number] => 17/909908 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909908 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909908
MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS Mar 17, 2021 Pending
Array ( [id] => 17853148 [patent_doc_number] => 20220283190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => METHODS AND DEVICES FOR DETECTION OF COAGULATION IMPAIRMENT [patent_app_type] => utility [patent_app_number] => 17/195615 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27190 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195615 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/195615
METHODS AND DEVICES FOR DETECTION OF COAGULATION IMPAIRMENT Mar 7, 2021 Abandoned
Array ( [id] => 18871401 [patent_doc_number] => 11859190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Methods and compositions for regulation of transgene expression [patent_app_type] => utility [patent_app_number] => 17/190994 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 24 [patent_no_of_words] => 21762 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 711 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190994 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/190994
Methods and compositions for regulation of transgene expression Mar 2, 2021 Issued
Array ( [id] => 18264946 [patent_doc_number] => 20230086188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION [patent_app_type] => utility [patent_app_number] => 17/908427 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33230 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908427 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908427
PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION Mar 2, 2021 Pending
Array ( [id] => 17095739 [patent_doc_number] => 20210283530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHOD OF PURIFYING THERAPEUTIC PROTEINS [patent_app_type] => utility [patent_app_number] => 17/188173 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188173 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188173
METHOD OF PURIFYING THERAPEUTIC PROTEINS Feb 28, 2021 Pending
Array ( [id] => 18333873 [patent_doc_number] => 20230125821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => MODIFIED TRANSGLUTAMINASE [patent_app_type] => utility [patent_app_number] => 17/908761 [patent_app_country] => US [patent_app_date] => 2021-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12258 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 613 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908761 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908761
MODIFIED TRANSGLUTAMINASE Feb 25, 2021 Pending
Array ( [id] => 19700200 [patent_doc_number] => 12194200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-14 [patent_title] => Silk fibroin-based microneedles and methods of making the same [patent_app_type] => utility [patent_app_number] => 17/173289 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 37 [patent_no_of_words] => 24169 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173289 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173289
Silk fibroin-based microneedles and methods of making the same Feb 10, 2021 Issued
Array ( [id] => 18226501 [patent_doc_number] => 20230065495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => MULTIPARTITE AND CIRCULARLY PERMUTED BETA-BARREL POLYPEPTIDES AND METHODS FOR THEIR USE [patent_app_type] => utility [patent_app_number] => 17/760165 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760165 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/760165
MULTIPARTITE AND CIRCULARLY PERMUTED BETA-BARREL POLYPEPTIDES AND METHODS FOR THEIR USE Feb 4, 2021 Abandoned
Array ( [id] => 16848195 [patent_doc_number] => 20210148940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS [patent_app_type] => utility [patent_app_number] => 17/160814 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160814 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/160814
METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS Jan 27, 2021 Abandoned
Array ( [id] => 18649773 [patent_doc_number] => 20230295594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => METHOD FOR THE EFFICIENT EXPRESSION AND PURIFICATION AND APPLICATION OF A RECOMBINANT FUSION PROTEIN OF MANNASE AND HOMOLOGUES THEREOF AND GLP-1 [patent_app_type] => utility [patent_app_number] => 18/020429 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020429 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/020429
METHOD FOR THE EFFICIENT EXPRESSION AND PURIFICATION AND APPLICATION OF A RECOMBINANT FUSION PROTEIN OF MANNASE AND HOMOLOGUES THEREOF AND GLP-1 Jan 25, 2021 Pending
Array ( [id] => 17052173 [patent_doc_number] => 20210261607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => PURIFICATION OF CHIMERIC FVIII MOLECULES [patent_app_type] => utility [patent_app_number] => 17/155935 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/155935
Purification of chimeric FVIII molecules Jan 21, 2021 Issued
Array ( [id] => 18567105 [patent_doc_number] => 20230257434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => CELL-DERIVED VESICLES COMPRISING TARGET PROTEIN AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/758825 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758825 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/758825
CELL-DERIVED VESICLES COMPRISING TARGET PROTEIN AND METHOD FOR PRODUCING SAME Jan 12, 2021 Abandoned
Array ( [id] => 18468833 [patent_doc_number] => 20230203115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND BETA-TCP BINDING PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/908835 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -61 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908835 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908835
THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND BETA-TCP BINDING PEPTIDES AND USES THEREOF Jan 4, 2021 Abandoned
Menu